Status:
COMPLETED
Epilepsy Adherence in Children and Technology (eACT)
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborating Sponsors:
National Institute of Nursing Research (NINR)
Medical University of South Carolina
Conditions:
Epilepsy
Eligibility:
All Genders
2-12 years
Phase:
NA
Brief Summary
Fifty-eight percent of children with new-onset epilepsy do not take their antiepileptic drugs (AEDs) as prescribed, which is associated with continued seizures, mortality, poor quality of life, and hi...
Detailed Description
Non-adherence to antiepileptic drugs (AEDs) is a common problem (i.e., 58% of patients have some level of non-adherence) for young children with newly diagnosed epilepsy, with potentially devastating ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Children ages 2-12 years
- Epilepsy diagnosis \< 2 years
- Ability to read/speak English
- Exclusion criteria:
- Major comorbid neurodevelopmental or medical disorders (e.g., Autism, diabetes)
- Plan to wean AEDs for 18 months
Exclusion
Key Trial Info
Start Date :
April 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
268 Patients enrolled
Trial Details
Trial ID
NCT03817229
Start Date
April 15 2019
End Date
August 1 2024
Last Update
October 30 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Childrens Hospital of Orange County
Orange, California, United States, 92868
2
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229
3
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205
4
Medical University of South Carolina
Charleston, South Carolina, United States, 29425